FATE Market Cap | FATE THERAPEUTICS INC

FATE THERAPEUTICS INC Market Cap

Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.

FATE THERAPEUTICS INC market cap for the quarter ending 2026-08-06 was $298.35M, a 139.53% increase year-over-year.
FATE THERAPEUTICS INC market cap for the quarter ending 2026-06-30 was $316.82M, a 145.63% increase year-over-year.
FATE THERAPEUTICS INC market cap for the quarter ending 2026-05-07 was $284.4M, a 158.44% increase year-over-year.
FATE THERAPEUTICS INC market cap for the quarter ending 2026-03-31 was $140.11M, a 54.75% increase year-over-year.
FATE THERAPEUTICS INC market cap for fiscal 2026 was $298.35M.
FATE THERAPEUTICS INC market cap for fiscal 2025 was $113.47M, a 39.64% decline from fiscal 2024.
FATE THERAPEUTICS INC market cap for fiscal 2024 was $187.98M, a 49.04% decline from fiscal 2023.
FATE THERAPEUTICS INC market cap for fiscal 2023 was $368.87M, a 62.43% decline from fiscal 2022.

Available history: 2013-11-11 to 2026-08-06
Data captured: 2026-08-06

Historical Market Cap

Date	Market Cap
2026-08-06	$298.35M
2026-06-30	$316.82M
2026-05-07	$284.4M
2026-03-31	$140.11M
2026-02-19	$161.61M
2025-12-31	$113.47M
2025-11-06	$119.39M
2025-09-30	$145.32M
2025-08-05	$124.56M
2025-06-30	$128.99M
2025-05-06	$110.05M
2025-03-31	$90.54M
2025-02-25	$140.95M
2024-12-31	$187.98M
2024-11-05	$305.24M
2024-09-30	$398.6M
2024-08-06	$488.54M
2024-06-30	$373.43M
2024-05-02	$466.71M
2024-03-31	$835.28M
2024-02-20	$700.62M
2023-12-31	$368.87M
2023-10-31	$178.47M
2023-09-30	$209M
2023-08-02	$370.59M
2023-06-30	$468.97M
2023-04-27	$574.57M
2023-03-31	$559.69M
2023-02-22	$619.4M
2022-12-31	$981.71M
2022-10-27	$2.01B
2022-09-30	$2.18B
2022-07-28	$3.12B
2022-06-30	$2.4B
2022-04-28	$3.06B
2022-03-31	$3.74B
2022-02-24	$3.27B
2021-12-31	$5.6B
2021-10-28	$5.35B
2021-09-30	$5.65B
2021-08-02	$8.1B
2021-06-30	$8.18B
2021-05-03	$8B
2021-03-31	$7.74B
2021-02-22	$9.47B
2020-12-31	$7.98B
2020-11-03	$3.98B
2020-09-30	$3.48B
2020-08-03	$2.88B
2020-06-30	$2.98B
2020-05-07	$2.16B
2020-03-31	$1.69B
2020-02-28	$2.22B
2019-12-31	$1.48B
2019-11-04	$1.16B
2019-09-30	$1.17B
2019-08-05	$1.26B
2019-06-30	$1.33B
2019-05-06	$1.17B
2019-03-31	$1.14B
2019-03-01	$1.08B
2018-12-31	$830.02M
2018-10-30	$781.32M
2018-09-30	$1.05B
2018-08-03	$522.44M
2018-06-30	$605.42M
2018-05-07	$556.07M
2018-03-31	$515.89M
2018-03-02	$700.25M
2017-12-31	$321.68M
2017-10-31	$198.84M
2017-09-30	$164.17M
2017-08-14	$127.97M
2017-06-30	$134.19M
2017-05-12	$166.02M
2017-03-31	$188.38M
2017-03-13	$209M
2016-12-31	$103.88M
2016-11-04	$66.59M
2016-09-30	$106.54M
2016-08-05	$60.97M
2016-06-30	$49.1M
2016-05-06	$49.36M
2016-03-31	$51.95M
2016-03-02	$49.06M
2015-12-31	$96.77M
2015-11-02	$133.53M
2015-09-30	$153.05M
2015-08-03	$197.99M
2015-06-30	$185.16M
2015-05-05	$102.59M
2015-03-31	$100.92M
2015-03-12	$104.84M
2014-12-31	$103.46M
2014-11-11	$81.25M
2014-09-30	$104.87M
2014-08-07	$119.47M
2014-06-30	$129.74M
2014-05-09	$140.52M
2014-03-31	$199.32M

Annual Market Cap

Date	Market Cap
2026-08-06	$298.35M
2025-12-31	$113.47M
2024-12-31	$187.98M
2023-12-31	$368.87M
2022-12-31	$981.71M
2021-12-31	$5.6B
2020-12-31	$7.98B
2019-12-31	$1.48B
2018-12-31	$830.02M
2017-12-31	$321.68M
2016-12-31	$103.88M
2015-12-31	$96.77M
2014-12-31	$103.46M
2013-12-31	$128.33M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Liminatus Pharma, Inc. (LIMN)	United States	$0.282B
Lexeo Therapeutics, Inc. (LXEO)	United States	$0.278B	-4.19
PALISADE BIO, INC. (PALI)	United States	$0.275B	-11.41
Invivyd, Inc. (IVVD)	United States	$0.270B	-2.42
Inhibikase Therapeutics, Inc. (IKT)	United States	$0.296B	-4.44
X4 Pharmaceuticals, Inc (XFOR)	United States	$0.297B	-4.99
SUTRO BIOPHARMA, INC. (STRO)	United States	$0.260B	-3.05
SAB Biotherapeutics, Inc. (SABS)	United States	$0.306B	-25.49
Century Therapeutics, Inc. (IPSC)	United States	$0.306B	-4.02
Lineage Cell Therapeutics, Inc. (LCTX)	United States	$0.241B	-10.35